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The importance of environmental exposures 
during intrauterine development on health 
throughout the life course is now well recog-
nized in the epidemiologic literature (Barker 
2004). The molecular mechanisms that under-
lie these observations remain unclear, although 
recent work suggests that alterations to placental 
function may lead to altered fetal development 
and programming, likely playing a critical role 
in mediating these associations (Higgins et al. 
2011; Lester and Padbury 2009). Throughout 
in utero development, the placenta, through the 
production of various enzymes and hormones, 
plays an important role in controlling growth 
and development through the transfer of nutri-
ents and waste and in protecting the fetus from 
many xenobiotic insults (Robins et al. 2011). 
Recent work has demonstrated that placental 
genetic and epigenetic profiles may possibly 
serve as markers (Filiberto et al. 2011; Sood 
et al. 2006) of the intrauterine and extrauterine 
environment (Nelissen et al. 2011).
DNA methylation is a key mode of epige-
netic regulation, which can lead to silencing 
of genomic regions. DNA methylation pat-
terns are essential for the growth and main-
tenance of tissue-specific expression profiles 
in different cell types during development, 
and these patterns become set during in utero 
development (Hajkova et al. 2002; Jaenisch 
1997; Rougier et al. 1998). This is true both 
in the fetus itself and in the placenta, where 
changes to the appropriate methylation pat-
terning have been linked to adverse placen-
tal morphology and birth outcomes (Serman 
et al. 2007; Sinclair et al. 2007).
Studies examining the impact of environ-
mental exposures on DNA methylation 
have often focused on the global extent of 
5-methyl  cytosine, using various approaches 
(Einstein et al. 2010; Pavanello et al. 2009), 
including the examination of repetitive ele-
ments as surrogate markers of global meth-
ylation (Choi et al. 2009; Lupski 2010; 
Weisenberger et al. 2005). These DNA repeti-
tive elements are made up of interspersed and 
tandem repeats and comprise at least half of 
the human genome (Zamudio and Bourc’his 
2010). Specifically, interspersed repeats are 
composed of retrotransposable elements such 
as long interspersed nuclear elements (LINEs) 
and short interspersed nuclear elements 
(SINEs). The LINE-1 subclass is the most 
common LINE, representing about 20% of 
the total human genome, whereas the most 
abundant type of SINE is the Alu element, 
as exemplified by AluYb8; together LINE 
and Alu sequences make up nearly one-third 
of the genome (Choi et al. 2009; Zamudio 
and Bourc’his 2010). The methylation sta-
tus of these elements may represent a passive 
dosimeter by being altered by various expo-
sures, although differences in the underlying 
structure of these elements and the unclear 
function of methylation of these regions sug-
gest that their alteration and their potential 
relevance need to be more carefully examined.
Thus, in this study we examined how the 
intrauterine environment is related to the 
methylation status of LINE-1 and Alu regions 
(specifically LINE-1 and AluYb8, respectively) 
in a functionally relevant fetal tissue, the pla-
centa. Further, we aimed to explore whether 
alterations to the methylation of these regions 
are associated with methylation of gene-asso-
ciated loci using a genomewide bioinformatic 
approach, in order to provide clues about the 
potential importance of these alterations.
Methods
Study population. Residual placental tis-
sues were obtained from 479 patients deliv-
ering at the Women and Infants Hospital 
in Providence, Rhode Island (USA), from 
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September 2008 through September 2009. 
This hospital performs approximately 85% of 
all obstetrical deliveries in Providence County 
(the largest population center in Rhode 
Island) and approximately 74% of all deliver-
ies in Rhode Island. Study eligibility criteria 
for mothers included healthy mothers ranging 
from 18 to 40 years of age, with no history of 
gestational diabetes, psychological dis  orders, 
or genetic disorders. Eligibility criteria for 
infants included viable infants of term births 
(born > 37 weeks of gestation) with no known 
genetic disorders or life-threatening illnesses. 
We selected infants considered small for ges-
tational age (SGA; < 10th percentile of birth 
weight) and matched non-SGA infants to these 
for infant sex, maternal age (± 3 years), and 
gestational age (± 2 days). For a description of 
placental tissue use, DNA extraction, and DNA 
purification procedures, see Supplemental 
Material, Supplementary Text 1 (http://dx.doi.
org/10.1289/ehp.1103927). All procedures 
were approved by the appropriate institutional 
review boards at Women and Infants Hospital 
and at Brown University, and participants were 
exempted from informed consent requirements.
Covariate data. All covariate data were 
collected from a structured inpatient medi-
cal record review. Birth weight percentile was 
calculated using the Fenton growth chart from 
gestational age and birth weight in grams 
(Fenton 2003), allowing us to account for 
gestational age in our birth weight metric and 
to create a normalized distribution for birth 
weight through birth weight percentile. Birth 
weight percentile was stratified into three clin-
ically meaningful categories to create birth 
weight status: SGA babies, defined as babies 
whose birth weight lies below the 10th per-
centile for that gestational age; appropriate for 
gestational age (AGA) babies, defined as babies 
whose birth weight lies above the 10th percen-
tile for that gestational age and below the 90th 
percentile for that gestational age; and large 
for gestational age (LGA) babies, defined as 
babies whose birth weight lies above the 90th 
percentile for that gestational age.
DNA methylation analysis. Repetitive 
element DNA methylation was determined 
by bisulfite pyrosequencing of the LINE-1 
and the AluYb8 repetitive elements as pre-
viously described (Bollati et al. 2007; Choi 
et al. 2009). Methylation extent was calcu-
lated as the mean LINE-1 methylation of four 
positions in the element and mean AluYb8 
methylation of five positions in the element. 
Pyrosequencing of these repeat elements was 
successful in 380 samples; we noted no signifi-
cant differences in the demographics or clini-
cal characteristics of these samples compared 
with the larger population.
To examine gene-related CpG methyla-
tion on a subset of the samples (n = 184), 
methylation was measured at 27,578 CpG 
loci using the Infinium HumanMethylation27 
BeadArray (Illumina, San Diego, CA). The 
microarrays were processed at the University of 
California–San Francisco Institute for Human 
Genetics and Genomics Core Facility, follow-
ing standard protocols. The methylation status 
for each individual CpG locus was calculated 
as the ratio of fluorescent signals:
  β = max(M,0)/[max(M,0)  
  + max(U,0) + 100],
using the average probe intensity for the meth-
ylated (M) and unmethylated (U) alleles. Ratios 
range from 0 to 1: β = 1 indicates complete 
methylation and β = 0 represents no methy-
lation. The data were then assembled using 
BeadStudio methylation software (version 
1.9.0; Illumina), without normalization, per 
the manufacturer’s instructions. We used array 
control probes to assess the quality of our sam-
ples and evaluate potential problems such as 
poor bisulfite conversion or color-specific issues 
for each array. Mahalanobis distance was used 
to screen outliers, and all CpG loci on X and Y 
chromosomes were excluded from the analysis, 
to avoid sex-specific methylation bias, leaving 
a final 26,486 autosomal CpG loci represent-
ing 13,890 unique genes (Poage et al. 2011). 
We and others have previously demonstrated 
that methylation of CpG loci detected through 
BeadArray platforms can be reliably replicated 
using alternative detection techniques includ-
ing pyrosequencing, MassARRAY analysis, and 
quantitative methylation-specific polymerase 
chain reaction (Ang et al. 2010; Christensen 
et al. 2010; Lin et al. 2010; Marsit et al. 2010; 
Poage et al. 2010, 2011; Wolff et al. 2010).
Statistical methods. Univariate associations 
of exposures and demographics with birth 
weight percentile status or with LINE-1 and 
AluYb8 extent were examined using Kruskal–
Wallis tests for continuous covariates and chi-
square tests for categorical covariates. A Pearson 
correlation was used to examine the correlation 
between LINE-1 and AluYb8 extents. Multiple 
linear regression was then used to evaluate the 
association between LINE-1 or AluYb8 methy-
lation levels and continuous birth weight per-
centile. All models were adjusted for infant 
sex and maternal age, body mass index (BMI) 
before pregnancy, ethnicity (non-Caucasian/
Caucasian), and alcohol, tobacco, and prenatal 
vitamin use during pregnancy (all yes/no). To 
check the linearity assumption for the regres-
sion models, we plotted residuals by birth 
weight percentile for all models and found no 
evidence for systematic nonlinearity.
To examine how repetitive element methy-
lation was related to gene-associated methyla-
tion, we restricted our analysis to placentas 
for which we had both repetitive element and 
gene-associated (array) methylation data for the 
26,486 CpG autosomal loci (n = 184). Using 
a data-driven recursively partitioned mixture 
model (RPMM), these CpG loci were clustered 
into 16 methylation classes based on like meth-
ylation pattern obtained from the array results, 
pruning the model after four splits to maintain 
power (Houseman et al. 2008). For each sub-
ject, 16 corresponding aggregate methylation 
values were obtained by averaging together 
average methylation β-values from all CpGs 
within each class. RPMM classes were labeled 
using a series of numbers, ranging from 1 to 
16 (with class 1 having the lowest methylation 
level and class 16 having the highest methyla-
tion level). RPMM was selected for this analy-
sis because we have demonstrated that RPMM 
provides more consistent clustering and more 
robustness in the selection of the number of 
classes because of its hierarchical presentation 
of classes, compared with metric hierarchical 
clustering, for this data set [see Supplemental 
Material, Supplementary Text 2 (http://dx.doi.
org/10.1289/ehp.1103927)]. An alternative, 
attribute-driven clustering scheme for the 
26,486 autosomal CpG loci was employed by 
grouping CpGs by epigenetically relevant bio-
informatic attributes: CpG island (CGI) sta-
tus (Takai and Jones 2002), polycomb group 
(PcG) target status of the associated gene [i.e., 
gene was described as a PcG target in at least 
one of Bracken et al. (2006), Lee et al. (2006), 
Schlesinger et al. (2007), and/or Squazzo et al. 
(2006)], presence within 1 kb of at least one 
of 258 computationally predicted transcrip-
tion factor binding site (TFBS) sequences 
obtained from the tfbsConsSites track of the 
University of California–Santa Cruz (UCSC) 
Genomes Browser site (TFBS z-score > 2) 
(Kent et al. 2002), and localization within each 
of the following classes of repetitive element as 
defined by the Repeatmasker track of Genomes 
Browser: Alu, LINE-1, LINE-2, and mamma-
lian wide-interspersed repeat elements (MIRs). 
This bioinformatic classification resulted in 
41 distinct bioinformatic classes containing 
at least one CpG (see Supplemental Material, 
Table 2). For each subject, 41 corresponding 
aggregate methylation values were obtained by 
averaging together average β-values from all 
CpGs within the class.
We used linear regression to determine the 
association between methylation of LINE-1 or 
AluYb8 and the aggregate methylation values 
for each of the 16 methylation classes deter-
mined by RPMM and the 41 bioinformatic 
classes. Omnibus tests for the overall asso-
ciation between each repetitive methylation 
and class methylation were obtained by per-
mutation test, using a test analogous to a 
Kolmogorov–Smirnov test. Specifically, a test 
statistic was constructed as the maximum abso-
lute t-statistic for the appropriate coefficient 
from the regression model, where the maxi-
mum was computed over the 16 or 41 individ-
ual regression models. The corresponding null Wilhelm-Benartzi et al.
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distribution, signifying a lack of association 
between repetitive element methylation and 
autosomal CpG methylation, was obtained by 
randomly permuting each repetitive element 
methylation marker with respect to aggregate 
methylation values of the RPMM and bioin-
formatic classes. Ten thousand permutations 
were used, and a hypothesized association was 
considered significant at the p ≤ 0.05 level.
To clarify the TFBSs overrepresented among 
loci whose methylation was associated with 
either LINE-1 or AluYb8 methylation, gene 
set enrichment analysis (GSEA) (Subramanian 
et al. 2005) was used. Across binding sites of 
transcription factors overrepresented within 
1 kb of loci, we compared the distribution of 
statistics representing the association between 
CpG-specific average β-value and each repeti-
tive element methylation markers. All statistical 
analyses were performed using the R statistical 
package (version 2.10; http://www.r-project.
org), and the R function was made available on 
the GSEA website, using permutation tests as 
described by Subramanian et al. (2005).
Results
Population characteristics. The characteristics 
of subjects used in these analyses (n = 380) 
are shown in Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1103927). 
Because subjects were selected based on SGA 
status and matched to non-SGA infants on sex, 
gestational age, and maternal age, we observed 
no significant differences in those characteris-
tics among birth weight groups (SGA, AGA, 
LGA). Significant differences were noted 
between groups for maternal ethnicity and 
maternal tobacco smoking during pregnancy, 
with a greater proportion of non-Caucasian 
infants (p = 0.01) and infants with exposure to 
tobacco smoke in the SGA category (p = 0.03). 
The vast majority of mothers reported pre-
natal vitamin use; only three subjects reported 
  alcohol consumption during pregnancy.
DNA methylation and infant growth. 
Mean LINE-1 and AluYb8 methylation levels 
differed significantly by birth weight status [see 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1103927); p < 0.0001]. 
Mean LINE-1 and AluYb8 methylation levels 
were also found to be weakly to moderately 
correlated, with a Pearson correlation of 0.29 
[95% confidence interval (CI): 0.20, 0.38]. 
To examine whether “global methylation” 
represented as an average of gene-associated 
methylation identified in a genomewide man-
ner was associated with infant growth, we 
tested for an association between birth weight 
percentile and mean methylation across the 
26,486 autosomal loci measured using the 
Illumina Infinium array in a subset of 184 pla-
centa samples. Mean methylation across the 
26,486 autosomal CpG loci was not signifi-
cantly associated with the birth weight groups 
(see Supplemental Material, Table 1). There 
were no significant differences in the distribu-
tions of the demographic characteristics of this 
subsample and the larger population examined 
for LINE-1 and AluYb8 methylation extent 
(data not shown).
To further evaluate the association 
between infant birth weight and repetitive ele-
ment methylation identified in the univariate 
analyses, controlled for confounders, we used 
multiple linear regression. These models dem-
onstrate that with a 10% increase in LINE-1 
mean methylation levels, birth weight per-
centile significantly increased by 9.7 (95% 
CI: 2.9, 16.6), and with a 10% increase in 
AluYb8 mean methylation levels, birth weight 
percentile significantly increased by 14.5 (95% 
CI: 4.9, 24.0) (Table 1). Both models were 
adjusted for infant sex and maternal age, BMI, 
ethnicity, and tobacco, alcohol and prenatal 
vitamin use during pregnancy. Infant sex and 
maternal ethnicity were also significant predic-
tors of birth weight percentile (Table 1); all 
other covariates were not significant.
DNA methylation and in utero exposures. 
Table 2 presents the results of our exploration 
of the differences in the measures of DNA 
methylation by various in utero exposures. 
Only AluYb8 methylation levels differed by 
infant sex (p = 0.04), with male infants hav-
ing slightly higher mean AluYb8 methylation 
(mean ± SD = 65.3 ± 3.3) than did female 
infants (64.6 ± 3.3). Furthermore, we found 
that mean AluYb8 levels differed significantly 
by maternal tobacco use during pregnancy 
(p < 0.01), whereas mean LINE-1 levels signif-
icantly differed only by maternal alcohol use 
during pregnancy (p = 0.02; Table 2). Array-
based mean methylation across the 26,486 
CpG loci did not differ by any of the in utero 
exposures explored.
Relationships between repetitive ele-
ment and gene associated methylation. To 
investigate the relationship between repeat 
element methylation and gene-associated 
methylation, we clustered the 26,486 auto-
somal CpG loci interrogated on the Infinium 
HumanMethylation27 BeadArray into 16 
methylation classes based on their methyla-
tion pattern using an RPMM [for the heat 
map of the 16 classes, see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1103927)]. This data-driven clustering 
allowed us to define stable classes of CpG loci 
demonstrating similar patterns of methyla-
tion, which we used to examine associations 
between methylation of these classes of CpGs 
and LINE-1 or AluYb8 methylation. By 
clustering, we hoped to uncover biologically 
meaningful groups of CpG loci, with similar 
Table 2. Repeat element methylation markers grouped by in utero exposures.
Group mean ± SD
Exposure n LINE-1 AluYb8 Array-based methylation
Sex
Male 190 51.7 ± 4.4 65.3 ± 3.3 0.238 ± 0.012
Female 190 51.7 ± 4.9 64.6 ± 3.3 0.237 ± 0.013
p-Value 0.90 0.04 0.28
Maternal ethnicity
Caucasian 217 51.4 ± 4.5 64.9 ± 3.3 0.239 ± 0.013
Non-Caucasian 163 52.0 ± 4.8 65.1 ± 3.3 0.236 ± 0.011
p-Value 0.21 0.47 0.17
Maternal tobacco use during pregnancy
Yes 36 52.9 ± 4.7 66.2 ± 2.3 0.240 ± 0.011
No 343 51.6 ± 4.6 64.8 ± 3.4 0.237 ± 0.012
p-Value 0.10 < 0.01 0.31
Maternal alcohol use during pregnancy
Yes 3 55.0 ± 1.0 66.0 ± 3.4 0.230 ± 0.001
No 377 51.7 ± 4.6 65.0 ± 3.3 0.238 ± 0.012
p-Value 0.02 0.66 0.51
Maternal prenatal vitamin use during pregnancy
Yes 314 51.8 ± 4.6 65.0 ± 3.3 0.238 ± 0.012
No 66 51.3 ± 4.7 64.6 ± 3.4 0.238 ± 0.014
p-Value 0.50 0.29 0.80
p-Values obtained from Kruskal–Wallis tests.
Table 1. Associations between infant growth and repetitive element methylation.
Covariate (n = 380) Linear regression effect estimate (95% CI) p-Value
Mean LINE-1 (per 10%) 9.7 (2.9, 16.6) 0.01
Infant sex 12.81 (6.54, 19.09) < 0.0001
White maternal ethnicity 7.06 (0.59, 13.53) 0.03
Mean AluYb8 (per 10%) 14.5 (4.9, 24.0) < 0.0001
Infant sex 12.05 (5.76, 18.33) < 0.0001
White maternal ethnicity 6.91 (0.46, 13.36) 0.04
All models were also adjusted for maternal age, BMI before pregnancy, tobacco, alcohol, and prenatal vitamin use dur-
ing pregnancy. Infant sex uses female sex as the referent.Repetitive element methylation and altered fetal growth
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methylation patterns, which may share bio-
logical characteristics such as comparable func-
tionality in certain developmental pathways or 
location in similar genomic regions.
The association between LINE-1 or 
AluYb8 methylation and average methylation 
within the RPMM-derived classes for each of 
the 184 individuals in the study is presented 
in Figure 1. There was an overall significant 
relationship between AluYb8 methylation and 
RPMM class methylation (p = 0.01); no asso-
ciation was observed between LINE-1 and 
RPMM class methylation. When considering 
class-specific relationships, a positive asso-
ciation was noted between AluYb8 methyla-
tion and methylation of CpGs encompassing 
the low to intermediately methylated class 9 
(Figure 1). Additionally, classes 7, 11, and 
12 were marginally positively associated with 
AluYb8 methylation levels, with CpGs exhib-
iting low to intermediate methylation.
To examine similarities in the genomic 
context of the CpGs making up these data-
driven RPMM classes, we examined the pro-
portion of CpG loci associated with specific 
DNA sequence features within each class, 
including location within a repetitive element 
(LINE-1, LINE-2, Alu, or MIR), within a 
CGI, or having the associated gene consid-
ered a PcG protein target gene (Figure 2). 
As expected, a greater proportion of CpGs in 
the relatively methylated (rightmost) classes 
9–12 are localized in repetitive elements 
(Figure 2A–D). Conversely, a high propor-
tion of CpGs in the relatively unmethylated 
classes 1–6 and 8 are in CGIs (Figure 2E). 
There was also interclass variation in the fre-
quency of CpGs association with PcG target 
genes, with classes 7 and 9 in particular hav-
ing a much higher proportion than the others 
(Figure 2F). Class 9, which was associated 
with AluYb8 methylation extent, contained 
a high proportion of CpG loci located within 
CGIs (81%) and whose genes are considered 
PcG target genes (32%).
Motivated by the variation in sequence 
features (bioinformatic attributes) observed 
between RPMM-based classes, we next per-
formed a bioinformatically informed cluster-
ing of CpG loci into classes, grouping CpGs 
according to their sequence context: presence 
within a CGI, LINE-1, LINE-2, Alu, or MIR 
element, or PcG target gene and proximity 
(≤ 1,000 bases) to any TFBS. This resulted in 
41 distinct bioinformatically derived classes, 
containing at least one CpG, based on bio-
informatic attributes [for the distribution of 
CpG loci by bioinformatically derived class, 
see Supplemental Material, Table 2 (http://
dx.doi.org/10.1289/ehp.1103927)]. The 
association between LINE-1 and AluYb8 
repetitive element methylation and aggregate 
methylation values of the autosomal CpG loci 
within each of the 41 bioinformatic classes 
Figure 1. Association of LINE-1 (A) and AluYb8 (B) methylation with mean RPMM class methylation. The 
colored dots indicate the degree of average CpG class methylation, as indicated by the key. The red 
dashed lines represent the null limits for the permutation distribution of regression coefficient t-statistics 
(t-stat), adjusted for multiple comparisons. 
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is depicted in Figure 3. There was an over-
all significant relationship between AluYb8 
methylation extent and bioinformatically 
derived CpG class methylation (p < 0.0001) 
but not between LINE-1 methylation and 
bioinformatically derived CpG class methyla-
tion. When considering class-specific relation-
ships, there was a positive association between 
AluYb8 methylation levels and mean methyla-
tion across loci allocated within a PcG target 
gene and LINE-2 element and proximal to 
a TFBS (class PcG/LINE-2/TFBS) and loci 
located within a CGI and PcG target gene and 
proximal to a TFBS (class CpG/PcG/TFBS).
GSEA analysis. To expand on the bio-
informatically informed analysis, which sug-
gested that methylation of CpG loci proximal 
to a TFBS were associated with AluYb8 meth-
ylation, we performed a GSEA using specific 
TFBS, obtained from the UCSC Genomes 
Browser. Specifically, each of the 26,486 
autosomal CpG loci are simultaneously eval-
uated for their association with LINE-1 or 
AluYb8 methylation extent and the genomic 
locations or TFBS that are overrepresented 
within 1 kb of the loci [for the GSEA results, 
see Supplemental Material, Figure 2 (http://
dx.doi.org/10.1289/ehp.1103927)]. Only 
three TFBS genes were overrepresented 
among loci whose methylation was associated 
with LINE-1 methylation: MEF2, TBX1, 
and POU2F1. For those overrepresented 
among loci associated with AluYb8 methyla-
tion, there were a number of developmentally 
related TFBS genes (CUX1, CHX10, PAX4, 
PPARG, TAL1/ITF2 heterodimer, HAND1, 
MYOD, OCT), as well as those involved in 
cell processes (ACTR3B, S8), gene expression 
(NFE2L), lipid/sterol homeostasis (NR3C1), 
and immune modulation (GATA1). Only 
POU2F1 was found to be overrepresented 
among loci associated with both LINE-1 and 
AluYb8 methylation.
Discussion
In this study, we have identified significant 
associations between infant growth, in utero 
exposures, and repetitive element methylation 
in placental tissue. Moreover, by examining 
the relationship between repetitive element 
DNA methylation and genomewide (array) 
gene-associated methylation, this work sug-
gests potential epigenetic mechanisms under-
lying changes to placental function that may 
lead to altered fetal development and pro-
gramming. In addition, we have identified 
particular regions of the genome susceptible to 
alterations by the intrauterine environment.
Overall, AluYb8 had higher DNA 
methylation levels than did LINE-1, which 
may be due to the lower degree of C-to-T 
transition mutations owing to the younger 
age of AluYb8 elements (Choi et al. 2009). 
AluYb8 levels were found to marginally dif-
fer by infant sex, which is consistent with the 
previous literature in that repetitive element 
methylation markers in blood may vary by 
sex (Cash et al. 2011; Wilhelm et al. 2010). 
We found that birth weight percentile lev-
els increased by about 10 and 15 points, 
respectively, with a 10% increase in LINE-1 
or AluYb8 methylation levels, suggesting a 
strong association of repetitive element meth-
ylation markers with fetal growth. However, 
because LINE-1 and AluYb8 methylation lev-
els have a moderate correlation, it is possible 
that these two repetitive element methylation 
markers may explain both similar and dif-
ferent sources of variation in infant growth. 
Our analysis of the relationship between the 
extent of methylation at these elements and 
genomewide gene-associated methylation was 
aimed to better characterize the similarities 
and differences in the potential functional 
importance of these markers.
The approach to examining the relation-
ship between repetitive element methylation 
and gene-associated methylation was not 
designed to assess specific loci or genes associ-
ated with LINE-1 or AluYb8 methylation, 
but rather to evaluate whether methylation 
of particular groups of CpG loci with like 
methylation patterns or similar bioinformatic 
attributes were coordinately associated with 
LINE-1 or AluYb8 methylation, because this 
could inform on the process responsible for 
the variation between the two. Based on our 
data-driven RPMM approach, we observed 
that AluYb8 methylation was significantly and 
positively correlated with methylation at CpG 
loci in an intermediately methylated class 
containing loci that were located predomi-
nantly within CGIs and associated with PcG 
target genes. This was further substantiated 
in our bioinformatically informed classifica-
tion analysis, because we identified a signifi-
cant association between AluYb8 methylation 
and methylation of a group of loci defined by 
their position in a CGI, PcG target gene, and 
a TFBS, as well CpGs defined by association 
with a PcG target gene and LINE-2 element 
and proximal to a TFBS. We did not observe 
an overall association between any attribute-
defined gene-associated class methylation and 
LINE-1 methylation levels. This is in contrast 
to a previous study involving 12 fetal cord 
blood samples, which reported a significant 
correlation between LINE-1 methylation and 
methylation of specific loci residing mostly 
in CGIs (Fryer et al. 2011). This disparity 
Figure 3. Association of LINE-1 (A) and AluYb8 (B) methylation with bioinformatically derived CpG class 
methylation. The colored dots indicate the degree of average class methylation. The red dashed lines rep-
resent the null limits for the permutation distribution of regression coefficient t-statistics (t-stat), adjusted 
for multiple comparisons. 
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may reflect tissue-specific differences in these 
relationships, as well as the larger and there-
fore more precise nature of our examination. 
PcG targets are a family of developmentally 
related genes that can remodel chromatin 
and are responsible for silencing HOX genes, 
which are critical in embryonic development 
as well as potentially hundreds of other genes 
involved in cellular differentiation (Kirmizis 
et al. 2004; Simon and Kingston 2009). We 
observed that increasing AluYb8 methylation 
was associated with greater extents of methy-
lation at CpG loci located in a PcG target, 
and thus a change in the extent of methyla-
tion of AluYb8 may represent an alteration in 
the methylation of these key loci important in 
tissue development and differentiation.
Both bioinformatically informed CpG 
classes that were significantly associated with 
AluYb8 methylation contained loci that are 
proximal to TFBSs. Upon further exploration 
through GSEA, we observed an overrepre-
sentation of several TFBSs for transcription 
factors critical in development, cellular pro-
cesses, immune modulation, lipid or sterol 
homeostasis, and gene expression near loci 
associated with AluYb8, as well as a few devel-
opmental and cellular proliferation pathways 
for LINE-1. Specifically, POU2F1 binding 
sites were overrepresented among loci associ-
ated with both LINE-1 and AluYb8 extent. 
This transcription factor plays a role in the 
control of a wide range of genes, including 
small nuclear RNAs, immunoglobulins, his-
tone H2B, and the glucocorticoid receptor, 
and thus has a central role in controlling vari-
ous functions, including those of immuno-
modulation and steroid homeostasis in the 
placenta (Schonemann et al. 1998). Taken 
together, these results suggest that alterations 
to LINE-1 or AluYb8 methylation may act 
as a marker for key changes to the extent of 
methylation at loci targeted by important 
transcription factors for normal develop-
ment and placenta processes necessary for 
appropriate growth.
When looking at each repetitive ele-
ment methylation marker grouped by vari-
ous in utero exposures, we found that mean 
AluYb8 methylation levels were significantly 
different by maternal tobacco use during preg-
nancy, similar to results from another group 
that found significantly different levels of cyto-
sine methylation by smoking status (Moore 
et al. 2008). Furthermore, mean LINE-1 
methylation levels were significantly different 
by maternal alcohol use during pregnancy; 
however, limited numbers may affect our pre-
cision, so this result should be confirmed in 
further analyses. This study was limited in its 
assessment of environmental exposures because 
of the low number of exposed individuals and 
low power, making this part of our analysis 
largely exploratory in nature. However, it will 
be increasingly important to examine, in larger 
studies, how additional specific exposures, such 
as lead as has been done by previous research-
ers (Pilsner et al. 2009), during intrauterine 
development affect these epigenetic markers in 
a more quantitative way.
Although a few other studies have cor-
related array-based methylation levels with 
repetitive element methylation markers (Fryer 
et al. 2011) and found at times good corre-
lation between the two, our results indicate 
that array-based methylation level may not 
be a good predictive marker of repetitive 
element methylation level in human pla-
centa tissue. Array-based mean methylation 
across the 26,486 CpG loci was not found to 
be associated with any of our in utero expo-
sures, contrasting with our repetitive element 
methylation markers. Additionally, LINE1, 
AluYb8, and specific array-based methylation 
loci often interrogate different genetic regions; 
therefore, their methylation may have a differ-
ential genomic impact. Furthermore, the diver-
gence of results observed between LINE-1 and 
AluYb8 reported throughout this work suggests 
that these repetitive element methylation mark-
ers are distinct measures and may not represent 
true, and potentially interchangeable, surro-
gates of “global” methylation. Although we 
found that these repetitive element indicators 
are weakly to moderately correlated, they have 
their own unique distributions of methylation 
values, consistent with previous comparisons 
between LINE-1 and Alu methylation in nor-
mal blood (Jintaridth and Mutirangura 2010). 
In addition, it is believed that genomic location 
and sequence context play a crucial role in the 
maintenance or loss of DNA methylation in 
these regions. For example, research has sug-
gested that Alu sequences often flank CGIs 
(Graff et al. 1997) and therefore may play a 
distinct role in both repetitive element and 
gene-directed methyla  tion. Differences between 
these markers can most likely be explained by 
the unequal distributions of these sequences 
throughout the genome, owing in some part to 
the evolutionary age of these two retrotranspos-
able elements (Zamudio and Bourc’his 2010). 
This may therefore be affecting the number 
of these elements in the genome and the func-
tional relevance of their methylation, particu-
larly in the placenta. As our results suggest, 
distinct mechanisms and selective pressures are 
likely responsible for their alteration.
The strengths of this study include the 
large sample size, population-based ascertain-
ment of placenta samples, quantitative assess-
ment of LINE-1 and AluYb8 methylation, 
and the use of a well-established, high-density 
methylation array for methylation profiling. 
Modest limitations of this study include the 
use of data from medical records, which may 
have reduced the quality of covariate data used 
in this study. This may have been especially 
relevant in our measurement of maternal 
tobacco, alcohol, and prenatal vitamin use 
and could have potentially introduced a bias 
toward the null. Additionally, because Rhode 
Island is a small state representing a small 
geographic area, recruiting participants from 
this state may affect the generalizability of our 
findings; however, because the Women and 
Infants Hospital performs > 85% of all obstet-
rical deliveries in Providence County (the 
largest population center in Rhode Island), 
we believe this limitation is compensated for 
to some extent by the lack of ascertainment 
bias in this population-based study.
Conclusions
Overall, we have demonstrated that altered 
methylation of repetitive elements in the pla-
centa is associated with birth outcome and 
with specific environmental exposures encoun-
tered by the fetus. Of course, birth weight 
is likely a proxy for a complex interplay of 
underlying etiologic mechanisms and envi-
ronmental factors that overall contribute to 
infant health at birth and beyond. Our data 
also suggest that these alterations may reflect 
underlying functional epigenetic alterations 
to genes important in placental growth and 
development. Confirmation and expansion 
of these findings in additional populations, 
with additional environmental data and more 
comprehensive methylation profiles as well as 
studies of the mechanism of these alterations, 
will provide additional valuable insights into 
the epigenetic mechanisms controlling fetal 
growth. These data also further the hypoth-
esis that the intrauterine environment acting 
through epigenetic alteration of the placenta is 
a key mechanism to explain the developmental 
origins of health and disease and suggest that 
enhanced examinations of the importance of 
placental epigenetic variation in health out-
comes should be undertaken.
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